Scottish COVID CAncer iMmunity Prevalence (SCCAMP) study
Is COVID-19 immunity reduced in cancer patients?
It is still uncertain to what extent cancer or cancer treatments reduce immunity. More research is needed. We know that antibody tests can indicate prior COVID-19 infection but it is important that we find out how many people with cancer have antibodies against COVID-19 and whether the antibody response is affected by their treatment. We also need to understand if having detectable antibodies leads to good immunity from subsequent re-infection with COVID-19.
The SCCAMP study is trying to find out?
SCCAMP is a very simple blood sampling study. Blood samples will be taken regularly over a 1 year period from consenting patients who are attending the NHS for routine treatment for cancer in Scotland. Blood samples will be tested for markers of immune response, including COVID-19 antibody levels.
How do I take part?
SCCAMP is currently recruiting patients who are undergoing treatment at the Edinburgh Cancer Centre. If you would like to take part please speak to a member of your clinical team.
What happens if I join?
Download the full Patient Information Sheet
